$1.86
0.07[3.91%]
At close: Apr 26
$1.86
0[0.00%]
PreMarket: 4:43AM EDT
TRACON Pharma
(NASDAQ:TCON)TRACON Pharma Stock (NASDAQ:TCON), Analyst Ratings, Price Targets, Predictions
TRACON Pharmaceuticals Inc has a consensus price target of $4.4, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 3, 2024, March 6, 2024, and November 20, 2023. With an average price target of $5.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 186.74% upside for TRACON Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JonesTrading
Baird
Maxim Group
Alliance Global Partners
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for TRACON Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | TCON | Buy Now | TRACON Pharma | $1.86 | 61.29% | HC Wainwright & Co. | Edward White | $120 → $60 | Maintains | Buy | Get Alert |
| 03/06/2024 | TCON | Buy Now | TRACON Pharma | $1.86 | 222.58% | HC Wainwright & Co. | Edward White | $140 → $120 | Maintains | Buy | Get Alert |
| 11/20/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | 276.34% | HC Wainwright & Co. | Edward White | → $140 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | — | JonesTrading | Soumit Roy | — | Downgrade | Buy → Hold | Get Alert |
| 08/15/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | 61.29% | Baird | Joel Beatty | $140 → $60 | Maintains | Outperform | Get Alert |
| 05/11/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | 61.29% | Maxim Group | Jason McCarthy | $160 → $60 | Maintains | Buy | Get Alert |
| 05/11/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | 276.34% | Baird | Joel Beatty | $160 → $140 | Maintains | Outperform | Get Alert |
| 03/09/2023 | TCON | Buy Now | TRACON Pharma | $1.86 | 545.16% | HC Wainwright & Co. | Edward White | → $240 | Reiterates | → Buy | Get Alert |
| 02/23/2022 | TCON | Buy Now | TRACON Pharma | $1.86 | 437.63% | Baird | Joel Beatty | → $200 | Initiates | → Outperform | Get Alert |
| 06/04/2021 | TCON | Buy Now | TRACON Pharma | $1.86 | 598.92% | Alliance Global Partners | — | → $260 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for TRACON Pharma (TCON)?
The latest price target for TRACON Pharma (NASDAQ: TCON) was reported by HC Wainwright & Co. on April 3, 2024. The analyst firm set a price target for $3.00 expecting TCON to rise to within 12 months (a possible 61.29% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TRACON Pharma (TCON)?
The latest analyst rating for TRACON Pharma (NASDAQ: TCON) was provided by HC Wainwright & Co., and TRACON Pharma maintained their buy rating.
When was the last upgrade for TRACON Pharma (TCON)?
There is no last upgrade for TRACON Pharma.
When was the last downgrade for TRACON Pharma (TCON)?
The last downgrade for TRACON Pharmaceuticals Inc happened on August 21, 2023 when JonesTrading changed their price target from N/A to N/A for TRACON Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for TRACON Pharma (TCON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TRACON Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TRACON Pharma was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating TRACON Pharma (TCON) correct?
While ratings are subjective and will change, the latest TRACON Pharma (TCON) rating was a maintained with a price target of $6.00 to $3.00. The current price TRACON Pharma (TCON) is trading at is $1.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.